
The LP Foundation Joins Rutgers University and Sirica Therapeutics in Omni One Neurodivergent Therapy Initiative Pilot Will Evaluate AI-Driven, Movement-Based Therapy Across Multiple Real-World Care Settings AUSTIN, Texas, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Virtuix Holdings Inc. (NASDAQ: VTIX), a leading developer of AI-driven, full-body simulation systems, today announced the expansion of its healthcare initiative focused on serving neurodivergent communities, adding The LP Foundation as a partner in the deployment of immersive educational and enrichment experiences using Virtuix's Omni One platform.










